AmericanHeartJ (@americanheartj) 's Twitter Profile
AmericanHeartJ

@americanheartj

The American Heart Journal has been a trusted resource for cardiologists and general practice physicians since 1925.

ID: 4890380513

linkhttp://www.ahjonline.com calendar_today09-02-2016 01:11:18

3,3K Tweet

10,10K Followers

5,5K Following

AmericanHeartJ (@americanheartj) 's Twitter Profile Photo

OPEN ACCESS: Design and rationale of the Comprehensive intelligent Hypertension managEment SyStem (CHESS) evaluation study: A cluster randomized controlled trial for hypertension management in primary care pubmed.ncbi.nlm.nih.gov/38575049/ #Cardiology

OPEN ACCESS: Design and rationale of the Comprehensive intelligent Hypertension managEment SyStem (CHESS) evaluation study: A cluster randomized controlled trial for hypertension management in primary care
pubmed.ncbi.nlm.nih.gov/38575049/
#Cardiology
AmericanHeartJ (@americanheartj) 's Twitter Profile Photo

Low-density lipoprotein cholesterol response to statins according to comorbidities and co-medications: A population-based study pubmed.ncbi.nlm.nih.gov/38710378/ #Cardiology

Low-density lipoprotein cholesterol response to statins according to comorbidities and co-medications: A population-based study
pubmed.ncbi.nlm.nih.gov/38710378/
#Cardiology
AmericanHeartJ (@americanheartj) 's Twitter Profile Photo

Uptake of SGLT2i and Outcomes in Patients with Diabetes and Heart Failure: A Population-Based Cohort and a Specialized Clinic Cohort pubmed.ncbi.nlm.nih.gov/38670300/ #Cardiology

Uptake of SGLT2i and Outcomes in Patients with Diabetes and Heart Failure: A Population-Based Cohort and a Specialized Clinic Cohort
pubmed.ncbi.nlm.nih.gov/38670300/
#Cardiology
AmericanHeartJ (@americanheartj) 's Twitter Profile Photo

Comparison of downsizing strategy (HANGZHOU Solution) and standard annulus sizing strategy in type 0 bicuspid aortic stenosis patients undergoing transcatheter aortic valve replacement: Rationale and design of a randomized clinical trial pubmed.ncbi.nlm.nih.gov/38701961/ #Cardiology

Comparison of downsizing strategy (HANGZHOU Solution) and standard annulus sizing strategy in type 0 bicuspid aortic stenosis patients undergoing transcatheter aortic valve replacement: Rationale and design of a randomized clinical trial
pubmed.ncbi.nlm.nih.gov/38701961/
#Cardiology
AmericanHeartJ (@americanheartj) 's Twitter Profile Photo

Premorbid physical activity and prognosis after incident myocardial infarction: The atherosclerosis risk in communities study pubmed.ncbi.nlm.nih.gov/38723879/ #Cardiology

Premorbid physical activity and prognosis after incident myocardial infarction: The atherosclerosis risk in communities study
pubmed.ncbi.nlm.nih.gov/38723879/
#Cardiology
AmericanHeartJ (@americanheartj) 's Twitter Profile Photo

A randomized clinical trial of catheter ablation and antiarrhythmic drug therapy for suppression of ventricular tachycardia in ischemic cardiomyopathy: The VANISH2 trial pubmed.ncbi.nlm.nih.gov/38649085/ #Cardiology

A randomized clinical trial of catheter ablation and antiarrhythmic drug therapy for suppression of ventricular tachycardia in ischemic cardiomyopathy: The VANISH2 trial
pubmed.ncbi.nlm.nih.gov/38649085/
#Cardiology
AmericanHeartJ (@americanheartj) 's Twitter Profile Photo

Rationale and design of a single-center randomized trial to compare the graft patency between the radial artery and the no-touch saphenous vein in coronary artery bypass grafting surgery (GRAFT-CAB Study) pubmed.ncbi.nlm.nih.gov/38710379/ #Cardiology

Rationale and design of a single-center randomized trial to compare the graft patency between the radial artery and the no-touch saphenous vein in coronary artery bypass grafting surgery (GRAFT-CAB Study)
pubmed.ncbi.nlm.nih.gov/38710379/
#Cardiology
AmericanHeartJ (@americanheartj) 's Twitter Profile Photo

Prediction of 30-day mortality after surgery for infective endocarditis using risk scores: Insights from a European multicenter comparative validation study pubmed.ncbi.nlm.nih.gov/38848985/ #Cardiology

Prediction of 30-day mortality after surgery for infective endocarditis using risk scores: Insights from a European multicenter comparative validation study
pubmed.ncbi.nlm.nih.gov/38848985/
#Cardiology
AmericanHeartJ (@americanheartj) 's Twitter Profile Photo

OPEN ACCESS: Restoring microvascular circulation with diagnostic ultrasound and contrast agent: rationale and design of the REDUCE trial pubmed.ncbi.nlm.nih.gov/38944262/ #Cardiology

OPEN ACCESS:  Restoring microvascular circulation with diagnostic ultrasound and contrast agent: rationale and design of the REDUCE trial
pubmed.ncbi.nlm.nih.gov/38944262/
#Cardiology
AmericanHeartJ (@americanheartj) 's Twitter Profile Photo

Fully automated quantitative coronary angiography versus optical coherence tomography guidance for coronary stent implantation (FLASH): Study protocol for a randomized controlled noninferiority trial pubmed.ncbi.nlm.nih.gov/38723880/ #Cardiology

Fully automated quantitative coronary angiography versus optical coherence tomography guidance for coronary stent implantation (FLASH): Study protocol for a randomized controlled noninferiority trial
pubmed.ncbi.nlm.nih.gov/38723880/
#Cardiology
AmericanHeartJ (@americanheartj) 's Twitter Profile Photo

Association of disproportionate liver fat with markers of heart failure: The multi-ethnic study of atherosclerosis pubmed.ncbi.nlm.nih.gov/38777028/ #Cardiology

Association of disproportionate liver fat with markers of heart failure: The multi-ethnic study of atherosclerosis
pubmed.ncbi.nlm.nih.gov/38777028/
#Cardiology
AmericanHeartJ (@americanheartj) 's Twitter Profile Photo

Impact of the clinical frailty scale on long-term outcomes after transcatheter aortic valve implantation pubmed.ncbi.nlm.nih.gov/38876408/ #Cardiology

Impact of the clinical frailty scale on long-term outcomes after transcatheter aortic valve implantation
pubmed.ncbi.nlm.nih.gov/38876408/
#Cardiology
AmericanHeartJ (@americanheartj) 's Twitter Profile Photo

OPEN ACCESS: Design and rationale of the CLEAR SYNERGY (OASIS 9) trial: A 2x2 factorial randomized controlled trial of colchicine versus placebo and spironolactone vs placebo in patients with myocardial infarction pubmed.ncbi.nlm.nih.gov/38936755/ #Cardiology

OPEN ACCESS: Design and rationale of the CLEAR SYNERGY (OASIS 9) trial: A 2x2 factorial randomized controlled trial of colchicine versus placebo and spironolactone vs placebo in patients with myocardial infarction
pubmed.ncbi.nlm.nih.gov/38936755/
#Cardiology
AmericanHeartJ (@americanheartj) 's Twitter Profile Photo

Characterization of peripheral artery disease and associations with traditional risk factors, mobility, and biomarkers in the project baseline health study pubmed.ncbi.nlm.nih.gov/38969081/ #Cardiology

Characterization of peripheral artery disease and associations with traditional risk factors, mobility, and biomarkers in the project baseline health study
pubmed.ncbi.nlm.nih.gov/38969081/
#Cardiology
AmericanHeartJ (@americanheartj) 's Twitter Profile Photo

Decreased postpartum exercise capacity after a diagnosis of pre-eclampsia: Implications for CVD risk prediction pubmed.ncbi.nlm.nih.gov/38944263/ #Cardiology

Decreased postpartum exercise capacity after a diagnosis of pre-eclampsia: Implications for CVD risk prediction
pubmed.ncbi.nlm.nih.gov/38944263/
#Cardiology
AmericanHeartJ (@americanheartj) 's Twitter Profile Photo

OPEN ACCESS: REGENERATE-COBRA: A phase II randomized sham-controlled trial assessing the safety and efficacy of intracoronary administration of autologous bone marrow-derived cells in patients with refractory angina pubmed.ncbi.nlm.nih.gov/38862073/ #Cardiology

OPEN ACCESS: REGENERATE-COBRA: A phase II randomized sham-controlled trial assessing the safety and efficacy of intracoronary administration of autologous bone marrow-derived cells in patients with refractory angina
pubmed.ncbi.nlm.nih.gov/38862073/
#Cardiology
AmericanHeartJ (@americanheartj) 's Twitter Profile Photo

Sirolimus-eluting iron bioresorbable scaffold versus cobalt-chromium everolimus-eluting stents in patients with coronary artery disease: Rationale and design of the IRONMAN-II trial pubmed.ncbi.nlm.nih.gov/38838969/ #Cardiology

Sirolimus-eluting iron bioresorbable scaffold versus cobalt-chromium everolimus-eluting stents in patients with coronary artery disease: Rationale and design of the IRONMAN-II trial
pubmed.ncbi.nlm.nih.gov/38838969/
#Cardiology